Hui Cao

3.6k total citations
72 papers, 1.1k citations indexed

About

Hui Cao is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Surgery. According to data from OpenAlex, Hui Cao has authored 72 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 38 papers in Gastroenterology and 23 papers in Surgery. Recurrent topics in Hui Cao's work include Gastrointestinal Tumor Research and Treatment (37 papers), Gastric Cancer Management and Outcomes (36 papers) and Metastasis and carcinoma case studies (18 papers). Hui Cao is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (37 papers), Gastric Cancer Management and Outcomes (36 papers) and Metastasis and carcinoma case studies (18 papers). Hui Cao collaborates with scholars based in China, South Korea and Spain. Hui Cao's co-authors include Ning Cai, X.‐L. Wu, Chunchao Zhu, Ming Wang, Lin Tu, Gang Zhao, Yangyang Wang, Amjad Parvaiz, Jamil Ahmed and Jun Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Hui Cao

66 papers receiving 1.1k citations

Peers

Hui Cao

PRM

SURGE

GASTR

ONCOL

Y Yamamura Japan

Akira Tari Japan

Takahisa Yamaguchi Japan

Moritz J. Strowitzki Germany

Nobuhiro Ozaki Japan

Fumihiko Tanioka Japan

Masashi Ishikawa Japan

Tomoko Uchiyama Japan

Paola Griseri Italy

Newman J. Sund United States

Y Yamamura Japan

Hui Cao

478 ×1.0

PRM

257 ×0.7

SURGE

80 ×0.2

GASTR

441 ×1.3

178 ×0.7

ONCOL

Citations per year, relative to Hui Cao Hui Cao (= 1×) peers Y Yamamura

Countries citing papers authored by Hui Cao

Since Specialization

Citations

This map shows the geographic impact of Hui Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Cao more than expected).

Fields of papers citing papers by Hui Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Cao. The network helps show where Hui Cao may publish in the future.

Co-authorship network of co-authors of Hui Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Cao. A scholar is included among the top collaborators of Hui Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Cao. Hui Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yang, et al.. (2025). MYR ameliorated MSG-induced immune dysfunction in HFD mice via modulation of gut microbiota and SCFAs metabolism. Food Bioscience. 65. 106115–106115.

Lü, Rui, Kiran Thakur, Hui Cao, et al.. (2024). Multi-omics reveal inhibitory effects of Protopanaxadiol on metastasis through PI3K-Akt and MAPK pathway in human cervical cancer HeLa cells. Food Bioscience. 63. 105731–105731. 1 indexed citations

Heinrich, Michael C., Jian Li, Robin L. Jones, et al.. (2023). Clinical efficacy of avapritinib in gastrointestinal stromal tumors (GIST) with different KIT genotypes: Post hoc analysis of the phase 1 NAVIGATOR and phase 1/2 CS3007-101 trials.. Journal of Clinical Oncology. 41(16_suppl). 11523–11523. 1 indexed citations

Ni, Bo, Xiang Xia, Linxi Yang, et al.. (2023). A single-center, prospective, single-arm, phase II trial to evaluate the adjuvant efficacy of camrelizumab with docetaxel plus S-1 for stage III (PD-L1⁺/dMMR/EBV⁺) gastric cancer after D2 resection.. Journal of Clinical Oncology. 41(16_suppl). e16089–e16089. 1 indexed citations

Zhang, Qingwei, Zhibo Yan, Yuxuan Zhao, et al.. (2023). Personalized radiomics signature to screen for KIT-11 mutation genotypes among patients with gastrointestinal stromal tumors: a retrospective multicenter study. Journal of Translational Medicine. 21(1). 726–726. 1 indexed citations

Li, Jian, Shirong Cai, Yongjian Zhou, et al.. (2022). Efficacy and Safety of Ripretinib in Chinese Patients with Advanced Gastrointestinal Stromal Tumors as a Fourth- or Later-Line Therapy: A Multicenter, Single-Arm, Open-Label Phase II Study. Clinical Cancer Research. 28(16). 3425–3432. 12 indexed citations

Suh, Yun‐Suhk, Hyuk‐Joon Lee, Ji‐Hyeon Park, et al.. (2022). Postoperative quality of life after gastrectomy in gastric cancer patients: a prospective longitudinal observation study. Annals of Surgical Treatment and Research. 103(1). 19–19. 13 indexed citations

Yang, Wenchang, Qian Liu, Bo Zhang, et al.. (2021). The effect of neoadjuvant imatinib therapy on outcome and survival in rectal gastrointestinal stromal tumors: A multiinstitutional study. Journal of Surgical Oncology. 124(7). 1128–1135. 10 indexed citations

Kong, Seong‐Ho, Ji‐Hyeon Park, Jong‐Ho Choi, et al.. (2020). Preservation of hepatic branch of the vagus nerve reduces the risk of gallstone formation after gastrectomy. Gastric Cancer. 24(1). 232–244. 21 indexed citations

10.

Shen, Yanying, Xinli Ma, Linxi Yang, et al.. (2020). Clinicopathologic characteristics, diagnostic clues, and prognoses of patients with multiple sporadic gastrointestinal stromal tumors: a case series and review of the literature. Diagnostic Pathology. 15(1). 56–56. 4 indexed citations

11.

Cao, Hui, Felix Berlth, Jia Xu, et al.. (2019). Pylorus-preserving gastrectomy for early cancer involving the upper third: can we go higher?. Gastric Cancer. 22(4). 881–891. 13 indexed citations

12.

Cao, Hui, et al.. (2018). [Clinical trials of laparoscopic gastric cancer surgery in South Korea: review and prospect].. PubMed. 21(2). 154–159. 2 indexed citations

13.

Wang, Yangyang, Chunchao Zhu, Wei Song, et al.. (2018). PD-L1 Expression and CD8⁺ T Cell Infiltration Predict a Favorable Prognosis in Advanced Gastric Cancer. Journal of Immunology Research. 2018. 1–10. 59 indexed citations

14.

Kong, Seong‐Ho, Shin‐Hoo Park, Michèle Diana, et al.. (2018). The anatomical configuration of the splenic artery influences suprapancreatic lymph node dissection in laparoscopic gastrectomy: analysis using a 3D volume rendering program. Surgical Endoscopy. 32(8). 3697–3705. 8 indexed citations

15.

Cao, Hui, et al.. (2017). [Development and progress of diagnosis and treatment for gastric cancer in China--what inspiration we gained from Japan and Korea].. PubMed. 20(10). 1109–1112. 1 indexed citations

16.

Zhang, Hongwei, et al.. (2016). Laparoscopic surgery in the treatment of incarcerated indirect inguinal hernia in children. Experimental and Therapeutic Medicine. 12(6). 3553–3556. 4 indexed citations

17.

Zhou, Ye, et al.. (2014). Is there a role of surgery in patients with recurrent or metastatic gastrointestinal stromal tumours responding to imatinib: A prospective randomised trial in China. European Journal of Cancer. 50(10). 1772–1778. 76 indexed citations

18.

Shen, Zhiyong, Hua Liu, & Hui Cao. (2014). Coffee consumption and risk of gastric cancer: An updated meta-analysis. Clinics and Research in Hepatology and Gastroenterology. 39(2). 245–253. 18 indexed citations

19.

Wang, Ming, Jia Xu, Yun Zhang, et al.. (2014). Gastrointestinal stromal tumor: 15-years’ experience in a single center. BMC Surgery. 14(1). 93–93. 22 indexed citations

20.

Zhang, Yun, Hui Cao, Ming Wang, et al.. (2009). [Analysis of clinicopathology and prognosis in 181 patients with gastrointestinal stromal tumors].. PubMed. 12(2). 150–4. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact